 Navidea Biopharmaceuticals, Inc. NYSE:NAVB Q1 2022 Results Conference Call May 12, 2022 5:00 PM ET Company Participants Michael Rosol - CMO Erika Eves - VP, Finance Administration Conference Call Participants Michael Okunewitch - Maxim Group Operator Welcome to the Navidea Biopharmaceuticals First Quarter 2022 Earnings Call and Business Update. I will now turn the call over to the Chief Medical Officer from Navidea, Michael Rosol, you may begin. 